濟民製藥(603222.SH):轉讓白水濟民醫院60%股權回購款延期收回
格隆匯12月24日丨濟民製藥(603222.SH)公佈,公司與控股子公司白水縣濟民醫院有限公司(以下簡稱“白水濟民醫院”)原股東趙選民簽署了《股權回購協議》。趙選民全額回購公司持有的白水濟民醫院全部股權(60%),回購對價為人民幣1.39億元,回購生效日確認為2019年6月3日。
截至本公告日公司已按期收到回購方趙選民支付的首期回購價款3861.65萬元及利息500萬元。根據協議,除首期回購款外,2019年12月15日前趙選民應繼續向公司支付本息合計金額不低於3000萬元。
日前,公司連續兩次收到趙選民出具的《關於延期支付白水濟民醫院股份回購款的承諾函》,請求上述款項的支付延期至2020年1月20日。承諾函提到“由於本人相關款項正在籌集中,無法按期支付,本人於2019年12月16日向貴公司申請延期至2019年12月28號。截至目前,根據本人資金籌集情況,預計12月28號仍無法支付相關款項,因此,本人再次向貴公司申請上述還款義務延期至2020年1月20日前支付。目前本人正積極籌措資金履行協議中約定的還款義務,屆時若再不能按時支付約定回購款項,本人同意自2019年12月15日起,回購利率由之前的每年12%上調至每年15%。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.